The Total Value Of The Two Largest Domestic Medical Beauty Brand Company Acquired By The Group Is Up To 500 Million Yuan.

Since 2016,

The idea of cross-border crossing of listed companies is even more unexpected. In June 13th evening, the announcement of the 63.49% shares of Sichuan Milan Bai Yu and Shenzhen Milan Bai Yu, Sichuan crystal skin, Xi'an crystal skin and Chongqing crystal skin medical beauty company 70% stake, the two largest domestic medical beauty of the acquisition.

The company's total valuation is up to 500 million yuan.

according to

According to the share bulletin, the company signed the equity pfer agreement with Zhang Yongqiang, Li Tao, Zhu Yangliu, Li Jiaping and Lanyu investment in June 12th. It intends to buy 63.49% stake in Milan Bai Yu, Sichuan, and 2 new graduates from Shenzhen Milan Bai Yu, Sichuan crystal skin and Taobao recruitment designers. Welcome to Xi'an, crystal skin, Changsha crystal skin and Chongqing crystal skin 5 companies 70% equity.

The total valuation of the above 6 companies was 500 million yuan, of which the valuation of Milan Bai Yu family in Sichuan reached 350 million yuan, indicating that the company occupies a pivotal position in the acquisition of the group.

According to information, Sichuan Milan Bai Yu was founded in September 2013 with a registered capital of 30 million yuan.

The company is a medical beauty hospital. Its main business is plastic surgery, micro plastic surgery, skin beauty and dental beauty. Its business area is more than 7600 square meters, and there are more than 100 medical and technical teams.

Financial data show that as of June 31st, the company's total assets amounted to 135 million yuan, and the total owners' equity amounted to 17 million 683 thousand yuan.

In 2015, the company's revenue was 153 million yuan, and its net profit was 7 million 314 thousand and 100 yuan.

For Sichuan Milan Bai Yu, Chengdu people may have heard a lot about it, which stems from the company put a lot of advertisements in radio stations and elevators.

Zhu Yuan, an analyst, said that after the acquisition, after the strategic investment in Korea dream group, the group continued to implement the development strategy of "China South Korea Industrial Synergy and multi brand linkage".

Analysis shows that the current domestic medical beauty hospital industry is in a process of intense integration.

With the increasingly stringent regulation and the increasingly fierce competition in the industry, leading enterprises with brand and scale advantages will continue to purchase integration and cross regional operation, further enhance the brand effect, accumulate loyal consumer groups and reduce the cost of acquiring customers.

Taking into account the practical difficulties faced by the apparel industry, Zhu Yuan also believes that the strategic integration of "walking with two legs" will be adopted by the company. On the one hand, it will develop high-end comprehensive medical beauty business to meet the diverse plastic needs of consumers, help build brand awareness, and constantly train and export doctors resources. On the other hand, it will lay a relatively low level of micro plastic business and establish a mature standardization system, which can quickly expand to the national market and produce scale effect.

On the basis of the existing women's clothing and cosmetics industry, the company steadily stands on the US industrial outlet, and is expected to continue to expand its pace on the basis of the current good start, and create a three-dimensional medical beauty service brand system.

In the past, he said that the reason for the pformation of medical beauty was mainly due to the demand level of clothing market affecting the level of sales revenue.

Although the company has occupied the highland of high-end women's clothing for a long time, with the rapid change of fashion trend in high-end women's clothing market, consumers' brand recognition has been reduced, which has a negative impact on the company's business performance.

At the same time, with the increasing attention and penetration of the international high-end brands to the Chinese market, the competition in this field is becoming increasingly fierce, and the company has some market volatility risks.

Reporters also learned from the annual report that in 2015, the company realized 1 billion 144 million yuan in operating income, down 7.38% from the same period last year, and achieved 1033747 sales of products, a decrease of 5.27% compared with the same period last year, and the average selling price of products was 1105 yuan / piece, down 2.33% from the same period last year.

The overall sales volume of clothing market increased and sales declined in 2015. However, because of the positioning of high-end brand women's clothing, sales promotion such as discount and price reduction did not bring about an increase in sales volume, leading to a decline in overall revenue of the company's apparel industry.